Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: a randomised, double-blind, four-arm parallel group dose-ranging study

Posted on by

Lancet Infectious Diseases
May 2022 Volume 22 Number 5 p563-742, e128-e158
https://www.thelancet.com/journals/laninf/issue/current

 

Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: a randomised, double-blind, four-arm parallel group dose-ranging study
Desiree Witte, et al.